InsidersTradesSigma
Track the ONCOSIL MEDICAL LTD share price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are quoted on AU AU, under the authority of ASX. Market capitalisation: €30m. The latest transaction was filed on 11 June 2026 (Change in Substantial Holding). Among the most active insiders: ABN 21 002 965 200. All data is free.
Analysts rate ONCOSIL MEDICAL LTD Buy (bullish).
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
ONCOSIL MEDICAL LTD is a company focused on developing cancer treatments, concentrating on innovative therapies. It is listed on the XASX market.